FBLGFibroBiologics, Inc.

Nasdaq fibrobiologics.com


$ 4.91 $ 0.33 (7.08 %)    

Friday, 28-Jun-2024 15:59:46 EDT
QQQ $ 479.98 $ -2.50 (-0.52 %)
DIA $ 391.11 $ -0.43 (-0.11 %)
SPY $ 544.70 $ -2.15 (-0.39 %)
TLT $ 91.77 $ -1.74 (-1.86 %)
GLD $ 215.03 $ 0.02 (0.01 %)
$ 4.99
$ 4.99
$ 0.00 x 0
$ 0.00 x 0
$ 4.67 - $ 6.03
$ 3.99 - $ 55.00
3,815,809
na
155.36M
$ -3.38
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-14-2024 03-31-2024 10-Q
2 02-29-2024 12-31-2023 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

- SEC Filing

Core News & Articles

Company Holds 150+ Patents For Fibroblast-Based Therapeutics And Cures For Chronic Diseases

Core News & Articles

- SEC Filing

Core News & Articles

This agreement comes ahead of entering into an anticipated master services agreement for the development and manufacture of Fib...

Core News & Articles

FibroBiologics, Inc. (NASDAQ:FBLG) ("FibroBiologics"), a clinical-stage biotechnology company with 150+ patents issued ...

Core News & Articles

FibroBiologics, Inc., (NASDAQ:FBLG) ("FibroBiologics"), a clinical-stage biotechnology company with 150+ patents issued...

Core News & Articles

FibroBiologics, Inc., (NASDAQ:FBLG) ("FibroBiologics"), a clinical-stage biotechnology company with 150+ patents issued...